HCAL
LFCR icon

HURRICANE CAPITAL ADVISORS LLC’s Lifecore Biomedical LFCR Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75K Sell
524
-6,855
-93% -$34.5K ﹤0.01% 744
2026
Q1 		$27.4K Sell
7,379
-2,750
-27% -$19K 0.01% 548
2025
Q4 		$82.9K Sell
10,129
-2,790
-22% -$20.6K 0.03% 450
2025
Q3 		$95.1K Hold
12,919
– – 0.02% 438
2025
Q2 		$105K Sell
12,919
-12,500
-49% -$84.3K 0.03% 358
2025
Q1 		$179K Buy
25,419
+12,110
+91% +$75.3K 0.06% 215
2024
Q4 		$98.9K Hold
13,309
– – 0.03% 333
2024
Q3 		$65.6K Sell
13,309
-43,312
-76% -$226K 0.02% 403
2024
Q2 		$290K Sell
56,621
-1,070
-2% -$6.34K 0.1% 148
2024
Q1 		$306K Buy
57,691
+8,410
+17% +$60.2K 0.09% 163
2023
Q4 		$305K Buy
+49,281
New +$342K 0.12% 118

Other funds holding LFCR

Wynnefield Capital
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
Legion Partners Asset Management
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
Greenhaven Road Investment Management
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
325 Capital
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's LFCR Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC reduced its Lifecore Biomedical (LFCR) stake by 93% in Q2 2026, selling an estimated $34.5K and leaving 524 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

HURRICANE CAPITAL ADVISORS LLC first reported a position in LFCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $306K in Q1 2024. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 524 shares of Lifecore Biomedical worth $2.75K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC sold 6,855 Lifecore Biomedical shares in Q2 2026, an estimated $34.5K.
  • Lifecore Biomedical made up ﹤0.01% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #744 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Lifecore Biomedical in Q4 2023 and has held it in 11 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Lifecore Biomedical position peaked at $306K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.